Identification of Tissue Types and Gene Mutations From Histopathology Images for Advancing Colorectal Cancer Biology.
Yuqi JiangCecilia Ka Wing ChanRonald C K ChanXin WangNathalie WongKa Fai ToSimon S M NgJames Yun Wong LauCarmen C Y PoonPublished in: IEEE open journal of engineering in medicine and biology (2022)
Objective: Colorectal cancer (CRC) patients respond differently to treatments and are sub-classified by different approaches. We evaluated a deep learning model, which adopted endoscopic knowledge learnt from AI-doscopist, to characterise CRC patients by histopathological features. Results: Data of 461 patients were collected from TCGA-COAD database. The proposed framework was able to 1) differentiate tumour from normal tissues with an Area Under Receiver Operating Characteristic curve (AUROC) of 0.97; 2) identify certain gene mutations (MYH9, TP53) with an AUROC > 0.75; 3) classify CMS2 and CMS4 better than the other subtypes; and 4) demonstrate the generalizability of predicting KRAS mutants in an external cohort. Conclusions: Artificial intelligent can be used for on-site patient classification. Although KRAS mutants were commonly associated with therapeutic resistance and poor prognosis, subjects with predicted KRAS mutants in this study have a higher survival rate in 30 months after diagnoses.
Keyphrases
- deep learning
- end stage renal disease
- poor prognosis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- machine learning
- prognostic factors
- heart failure
- wild type
- artificial intelligence
- emergency department
- long non coding rna
- gene expression
- patient reported outcomes
- case report
- big data
- optical coherence tomography
- adverse drug
- free survival